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Abstract Normal human fibroblasts have a limited replicative
potential in culture and eventually reach a state of irreversible
growth arrest, termed senescence. In a previous study aiming to
identify genes that are differentially regulated during cellular
senescence we have cloned clusterin/apolipoprotein J (Apo J), a
80 kDa secreted glycoprotein. In the current report we pursue
our studies and show that senescence of human diploid fibroblasts
is accompanied by up-regulation of both Apo J mRNA and
protein levels, but with no altered biogenesis, binding partner
profile or intracellular distribution of the two Apo J forms
detected. To analyze the causal relationship between senescence
and Apo J protein accumulation, we stably overexpressed the
Apo J gene in primary as well as in SV40 T antigen-
immortalized human fibroblasts and we showed no alteration of
the proliferative capacity of the transduced cells. Despite
previous reports on tumor-derived cell lines, overexpression of
Apo J in human fibroblasts did not provide protection against
apoptosis or growth arrest induced by hydrogen peroxide.
Overall, our results suggest that Apo J overexpression does not
induce senescence but it is rather a secondary consequence of the
senescence phenotype. To our knowledge this is the first report
that provides a functional analysis of human Apo J during
replicative senescence. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Normal human ¢broblasts have a limited replicative poten-
tial in culture and eventually reach a state of irreversible
growth arrest, termed senescence [1]. During serial passaging
primary cultures show a progressive decline in their ability to
synthesize DNA that is accompanied by signi¢cant changes at
the morphological, biochemical and molecular levels (re-
viewed in [2,3]). In addition, several studies have revealed
that cellular senescence relies on a genetic background. For
instance, cell fusion and micro-injection studies showed that
the senescent phenotype is dominant over immortality (re-
viewed in [4]). Following these initial studies, many genes
have been cloned and characterized as senescence-related
genes on the basis of their di¡erential expression upon senes-
cence induction [5^8]. Interestingly, by using oligonucleotide-
based arrays in di¡erent aging models it was found that about
1% of the genes examined were di¡erentially regulated sug-
gesting that aging and senescence are accompanied by signi¢-
cant alterations in gene expression patterns [9,10]. However,
only a small fraction of these genes have been analyzed so far
for their ability to a¡ect normal life-span when introduced
into primary proliferating and/or immortal cells (see Section
4). This kind of experimentation will provide insights into the
senescence phenotype and will determine which of these genes
are di¡erentially expressed in order to induce senescence or
alternatively, whether their overexpression is a consequence of
the induction of the senescence phenotype.
Recently, we took advantage of conditionally immortalized
SV40 T antigen (Ag) rat embryo ¢broblast cell lines which
undergo senescence upon T Ag inactivation [11] and, by ap-
plying di¡erential screening methods, we have cloned several
genes that associate with mammalian replicative senescence
[8]. One of the cloned genes encodes clusterin/apolipoprotein
J (Apo J). Initial analysis has shown that senescent cultures of
human or rat embryonic ¢broblasts as well as of human os-
teoblasts express high mRNA levels of Apo J [8,12]. Interest-
ingly, stress-inducing agents such as H2O2, ethanol, t-BHP or
heat shock also result in a signi¢cant up-regulation of Apo J
mRNA levels in these cells [8,12].
Apo J (also called SGP-2, clusterin, SP40, 40, complement
lysis inhibitor, gp80, glycoprotein III and T64) is a glycopro-
tein encoded by a single-copy gene. The protein is translated
from a single mRNA as a preprotein that matures by limited
proteolysis to form a disul¢de-linked (K- and L-chains) hetero-
dimeric glycoprotein of 70^80 kDa that is secreted by a num-
ber of cell types (reviewed in [13,14]). Apo J has been impli-
cated in a variety of physiological processes, including sperm
maturation, lipid transport, membrane remodelling and inhi-
bition of the complement cascade (reviewed in [14]). In addi-
tion, the Apo J gene is overexpressed in many severe physio-
logical disturbances such as castration-induced apoptosis in
rat ventral prostate, neuronal apoptosis and various diseases
including scrapie, Alzheimer’s disease or AIDS (reviewed in
[15]). Although Apo J induction is well established in such
pathological states, its precise involvement in these disorders
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remains puzzling. It has also been shown that the gene is up-
regulated in response to a variety of stress- and/or apoptosis-
inducing agents including tumor necrosis factor K (TNFK)
and transforming growth factor L treatment [16,17], heat
shock, UVA exposure and oxidative stress [8,12,18,19] as
well as treatment with chemotherapeutic drugs ([20], Trouga-
kos et al., submitted). Although it was initially thought that
Apo J was related to cell death it was then found that in fact,
the protein is overexpressed in the surviving neighboring cells
[16,21^23]. Moreover, it was shown that stable Apo J over-
expression in cancer cells could confer protection against var-
ious cytotoxic agents such as UV radiation, heat shock, oxi-
dative stress, TNFK and chemotherapeutic drugs ([16,17,
19,20], Trougakos et al., submitted), thus raising the hypoth-
esis that Apo J may be a survival gene exerting a protective
function on surviving cells. In addition, Apo J response to
some cytotoxic agents is accompanied by an altered biogenesis
that results in the appearance of stress-speci¢c cytoplasmic or
nuclear forms [17,24,25]. To add to the complexity regarding
Apo J function, recent reports propose that a truncated Apo J
nuclear form may induce death signals through interaction
with the DNA helicases Ku70 and Ku80 [26,27]. Therefore,
no genuine function has been attributed to the Apo J protein
so far.
All mentioned studies have focused on Apo J functions in
tumor-derived cell lines. However, hardly anything is known
regarding Apo J function in normal cells. In the current report
we pursue our previous studies by examining Apo J function
in proliferating and senescent human diploid ¢broblasts
(HDFs). We have veri¢ed, by a combination of molecular,
biochemical and cellular techniques, the senescence-related in-
duction of two Apo J protein forms and we provide evidence
for no altered biogenesis, partner binding, or intracellular dis-
tribution between cellular proliferation and senescence. Fur-
thermore, we have demonstrated that stable human Apo J
overexpression in primary or immortal human ¢broblasts
does not a¡ect their proliferative capacity. Finally, we have
shown that Apo J does not protect these cells from H2O2-
mediated apoptosis or growth arrest, contrary to recent re-
ports in tumor-derived cell lines [28]. According to these re-
sults a putative role of Apo J in human ¢broblasts is pro-
posed.
2. Materials and methods
2.1. Cells and cell culture
Human diploid WI-38 ¢broblasts and the SV40 T Ag-immortalized
WI-38 VA 13 cell line (WI-38/SV40 T Ag) were obtained from the
European Collection of Cell Cultures and were maintained in Dulbec-
co’s modi¢ed Eagle’s medium (Gibco Life Technologies), supple-
mented with 10% (v/v) fetal calf serum, 2 mM glutamine, 100 U/ml
penicillin, 100 Wg/ml streptomycin and 1% non-essential amino acids
(complete medium). WI-38 ¢broblasts were subcultured at a split ratio
1:2 when cells were con£uent until they reached senescence at about
45 cell population doublings (CPD). Primary rat embryonic ¢broblast
(REF) cultures were prepared from 12-day-old Sprague^Dawley rat
embryos after passaging 104 cells/cm2 every 72 h and they were main-
tained in the above-mentioned medium. In all experimental proce-
dures described below, cells were fed approximately 16 h prior to
the assay.
2.2. RNA analysis
Total RNA (20 Wg) from early passage proliferating (20 CPD) and
late passage senescent (43 CPD) WI-38 cells were extracted, electro-
phoresed, transferred to Hybond N membrane (Amersham) and hy-
bridized to human Apo J or 28S rRNA probes by standard methods
[29].
2.3. Immunoblot analysis
Cell monolayers were lysed in non-reducing or reducing Laemmli
bu¡er [30]. Analysis of Apo J levels in cell culture supernatants was
done in 100 Wl of culture medium diluted directly 1:1 in 2ULaemmli
bu¡er. Protein samples (25 Wg) were separated by 10% SDS^PAGE,
followed by immunoblotting analysis according to standard proce-
dures [30]. Antibodies used were: goat polyclonal antibody against
human Apo J (sc-6419; Santa Cruz Biotechnology), actin antibody
(sc-1616; Santa Cruz Biotechnology) and p21Waf1=Cip1=Sdi1 mouse
monoclonal antibody (sc-817; Santa Cruz Biotechnology). All anti-
bodies were diluted 1:1000 in 5% non-fat dry milk in Tris-bu¡ered
saline containing 0.1% Tween 20 (blocking solution). Secondary anti-
bodies used (horseradish peroxidase-conjugated anti-goat or -mouse
IgG; Santa Cruz Biotechnology) were diluted 1:2000 in blocking so-
lution. Immunoreactive bands were visualized by ECL enhanced
chemiluminescence (Amersham). Quanti¢cation of immunoreactive
protein bands was carried out by a densitometric analysis directly
from the X-ray ¢lms using a Molecular Dynamics (Sunnyvale) scan-
ner and the ImageQuant software.
2.4. Apo J immunoprecipitation
Early and late passage (CPD 20 and 43 respectively) WI-38 ¢bro-
blasts were starved in methionine-de¢cient medium for 1 h, followed
by pulse labeling for 1 h with 100 WCi/ml of [35S]methionine in me-
thionine-de¢cient medium. Cell monolayers were lysed in 50 mM
Tris^HCl (pH 8.0) containing 150 mM NaCl and either 1% or 0.5%
NP-40. Cell extracts were cleared by adding normal goat or mouse
serum and protein G agarose beads (Santa Cruz Biotechnology) for 1 h
at 4‡C. Apo J was speci¢cally immunoprecipitated by adding in the
pre-cleared extracts either 2 Wg of the goat anti-human Apo J anti-
body (sc-6419; Santa Cruz Biotechnology) or 1 Wg of anti-human Apo
J K-chain monoclonal antibody (Upstate Biotechnology) plus 1 Wg of
anti-Apo J monoclonal antibody (Quidel Company) for 1 h on ice.
Following addition of protein G agarose beads the binding reactions
were performed overnight at 4‡C. Immunoprecipitated protein com-
plexes were eluted from the agarose beads by boiling for 5 min in non-
reducing Laemmli bu¡er, were separated on 10% SDS^PAGE gels,
gels were ¢xed, ampli¢ed, dried and directly exposed to X-ray ¢lms.
2.5. Immuno£uorescence microscopy
Immuno£uorescence labeling of Apo J in early and late passage
WI-38 cells was done according to standard procedures [30]. Brie£y,
viable cells grown on coverslips were ¢xed with 3% freshly prepared
paraformaldehyde, followed by cell permeabilization with 0.2% Triton
X-100. Apo J was immunolocalized using the goat polyclonal anti-
body against human Apo J (sc-6419; Santa Cruz Biotechnology) di-
luted 1:50 in phosphate-bu¡ered saline containing 0.1% Tween 20 and
2% bovine serum albumin (blocking bu¡er) and then an anti-goat
IgG/£uorescein isothiocyanate-conjugated antibody (Santa Cruz Bio-
technology) diluted 1:250 in blocking bu¡er. Images of the mounted
coverslips were taken by using a Nikon 2000 confocal laser scanning
microscope (CLSM). Routine procedures applied as controls to dem-
onstrate the speci¢city of the antibody used were: (a) the usage of
normal goat serum instead of the reactive antibody and (b) omission
of the ¢rst antibody. In all control cases no immuno£uorescent back-
ground was observed.
2.6. Construction of Apo J expression vectors and generation of Apo
J-expressing WI-38/SV40 T Ag, WI-38 and REF cells
The full-length human Apo J cDNA (335 to +1507 bp) [31] was
isolated from pGAD10 vector (a generous gift of Dr. Howe) and was
directly subcloned either into the pcDNA3.1 (Invitrogen) mammalian
expression vector (pcDNA3.1ApoJ) or into the pBabe-puro retroviral
vector (pBabe-puroApoJ). The WI-38/SV40 T Ag and REF cells were
transfected with either pcDNA3.1ApoJ or pcDNA3.1 empty vector
using the electroporation method. Brie£y, 107 cells mixed with 50
Wg DNA were electroporated at 260 V, 960 WF (Gene Pulser1, Bio-
Rad). Transfected cells were split 48 h later and were maintained in
complete medium containing 400 Wg/ml G418. Colonies of stable
transfectants were isolated from the selection medium 3^4 weeks later
and propagated accordingly. The production of amphotropic re-
combinant retroviruses and infection of WI-38 ¢broblasts was per-
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formed essentially as described by Kolettas and Rosenberger [32].
Brie£y, amphotropic replication-defective recombinant retroviruses
were produced by transfecting ecotropic 8CRE cells with the retro-
viral constructs pBabe-puro (empty vector) or pBabe-puroApoJ and
collecting the released retroviral particles, following selection in pur-
omycin, to infect the amphotropic PA317 packaging cell line. WI-38
¢broblasts at CPD 23 were infected with the recombinant retroviruses
Babe-puro or Babe-puroApoJ collected from overnight cultures of
puro-resistant PA317, selected in 1.5 Wg/ml puromycin for 2 weeks
and propagated as mass cultures. In all cases, transfectants were
tested for Apo J protein expression levels by immunoblotting, as
described above.
2.7. TUNEL analysis, survival and clonogenic assays of WI-38/SV40 T
Ag ¢broblasts treated with H2O2
In order to detect DNA fragmentation in intact cells during H2O2-
induced apoptosis, terminal deoxynucleotidyl transferase (TdT)-medi-
ated dUTP nick end labeling (TUNEL) was performed using the in
situ Cell Death Detection Kit (£uorescein, Roche). Brie£y, cells were
seeded in 6-well plates in duplicate at a density of 5U104 cells/well,
allowed to attach overnight and exposed to various H2O2 concentra-
tions for 2 h. TUNEL reaction was applied as recommended by the
manufacturer and positive apoptotic nuclei were documented by £uo-
rescence microscopy. For the survival and the clonogenic assays, cells
were seeded in 6-well plates in duplicate at a density of 5U104 cells/
well (survival assay) or at the clonal density of 5U103 cells/well (clo-
nogenic assay) and allowed to attach overnight. Cells were then ex-
posed for 2 h to either 400 and 800 WM (survival assay) or 100 and
400 WM H2O2 (clonogenic assay) diluted in complete medium and
returned thereafter to normal complete medium. H2O2-treated surviv-
ing cells were identi¢ed by the trypan blue exclusion staining method
[29] 24 h after H2O2 removal. Growth ability (i.e. colony formation)
of the 100 and 400 WM H2O2-treated cells was assessed 1 week follow-
ing H2O2 treatment by directly counting the methylene blue-stained
colonies. Percentage of cell viability or colony formation refers to the
cells surviving or to the colonies formed following H2O2 treatment as
compared to the respective values obtained by the corresponding non-
treated control cells. All experiments were done in duplicate and the
presented results refer to the mean values and standard deviation of
two independent experiments.
3. Results
3.1. Cellular senescence is accompanied by up-regulation of
Apo J, but with no altered biogenesis or di¡erentiation of
its intracellular distribution
We have shown in previous studies that there is a transcrip-
tional up-regulation of the Apo J gene during replicative sen-
escence of various cell types [8,12]. Therefore we determined
whether this mRNA up-regulation is also re£ected at the pro-
tein level and whether there is an induction of any novel
senescence-induced Apo J form(s) or alteration of the intra-
cellular distribution of the protein, as has been reported in
other cellular processes [17,24,25]. As shown in Fig. 1A RNA
analysis revealed a signi¢cant overexpression of the Apo J
mRNA levels in late passage senescent HDFs as compared
to early passage proliferating cells, in agreement with previous
data. Since Apo J is constitutively secreted by mammalian
cells [14], we then analyzed the Apo J protein levels in cell
culture supernatants and in whole cell lysates of proliferating
and senescent cells. Immunoblotting analysis shown in Fig. 1B
demonstrated an approximate 2.5-fold induction of all the
immunoreactive Apo J bands in senescent HDFs. In both
cell lysates two Apo J forms were detected with molecular
weights, under non-reducing conditions, of about 80 and 68
kDa (Fig. 1B, right panel). In agreement with previous studies
focusing on the various Apo J forms and their processing ([14]
and references therein), the 80 kDa form that corresponds to
the secreted Apo J was also found in cell culture supernatants
(Fig. 1B, left panel) and dissociates into two subunits (K and
L) under reducing conditions by cleavage at the Asp227-Ser228
residues. Accordingly, the 68 kDa band that corresponds to
the cytoplasmic Apo J, as expected, was not found in cell
culture supernatants and it did not dissociate into K and L
subunits under reducing conditions (Fig. 1B).
To verify further the enhanced secretion rate of the 80 kDa
Apo J form in senescent HDFs, the secreted Apo J amount in
the culture supernatants of about 70% con£uent £asks of
proliferating and senescent WI-38 cells was analyzed at di¡er-
ent time intervals following the addition of fresh complete
medium. As demonstrated in Fig. 1C at all eight distinct
time points examined (from 15 min to 24 h), the secretion
rate and thus the extracellular levels of the 80 kDa Apo J
form are higher in late passage HDFs as compared to the
early passage cultures. Moreover, the observation that the
protein amount in the medium (in both cell states) is contin-
uously increasing provides evidence that in senescent cells (as
in the proliferating ones) the protein is continuously secreted
via the constitutive secretory pathway. Thus the enhanced
Apo J levels in senescent cells are not due to their inability
to secrete the protein.
Finally, to examine whether the quantitative di¡erences
seen in the Apo J protein expression levels between prolifer-
ating and senescent HDFs corresponds to a di¡erentiated in-
tracellular distribution pattern, we immunolocalized Apo J in
these cells. As is apparent in the CLSM images shown in Fig.
1D, in both cellular states a dispersed punctuated cytoplasmic
distribution, indicative of vesicular packaging, was observed.
In accordance with the previously shown results the immuno-
£uorescence signal observed in senescent cells appeared to be
signi¢cantly enhanced as compared to their young counter-
parts. In summary these data demonstrate that there is no
Apo J altered biogenesis or intracellular distribution during
replicative senescence. Moreover, both pathways (through
which the nascent Apo J polypeptide is post-translationally
processed) that lead to the accumulation of the extracellular
(80 kDa) and the intracellular (68 kDa) Apo J forms are
regulated in a similar manner in both proliferating and sen-
escent HDFs.
3.2. Comparative Apo J immunoprecipitation in proliferating
and senescent WI-38 ¢broblasts
Next we analyzed whether the progression of replicative
senescence is accompanied by an altered pro¢le of Apo J
co-immunoprecipitated intracellular proteins. For these ex-
periments Apo J was comparatively immunoprecipitated
from metabolically labeled early and late passage WI-38 cells.
Cells were lysed under stringent (1% NP-40) or less stringent
(0.5% NP-40) conditions and Apo J was immunoprecipitated
either with the polyclonal antibody used for the immunoblot-
ting analysis or with a combination of two monoclonal anti-
bodies that recognize both the 80 and 68 kDa Apo J forms. A
representative analysis is shown in Fig. 2. In all conditions
used several polypeptides were found to co-immunoprecipitate
with Apo J but none of them appeared to interact with Apo J
in a selective manner in early or late passage ¢broblasts. (As
most of the reported Apo J binding ligands are extracellular
molecules [14,24,27], we are currently characterizing by ma-
trix-assisted laser desorption ionization mass spectrometry the
major Apo J binding intracellular ligands.) Although these
experiments do not exclude the possibility that Apo J may
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Fig. 1. Apo J gene expression, protein levels and cell distribution in early passage (E) proliferating (CPD 20) and late passage (L) senescent
(CPD 43) WI-38 ¢broblasts. A: Northern blot analysis of RNA transcript hybridized to the Apo J cDNA probe (upper panel). Stripping of
the blot and reprobing with a 28S rRNA probe was done to ensure equal RNA loading (lower panel). B: Immunoblotting analysis of the Apo
J amount present in the cell culture supernatants (lanes 1^4) and whole cell lysates (lanes 5^8) in early (lanes 1, 2, 5 and 6) and late passage
(lanes 3, 4, 7 and 8) WI-38 ¢broblasts in reducing (R) or non-reducing (NR) conditions (star in lane 2 indicates an antibody cross-reacting
band of unknown origin). Equal protein loading was further veri¢ed by stripping the membrane and reprobing with an actin antibody (lower
right panel). C: Immunoblotting analysis of Apo J accumulation in the cell culture supernatants at di¡erent time points (time 0 corresponds to
culture medium renewal) in early and late passage WI-38 ¢broblasts. D: CLSM images following Apo J immuno£uorescence localization in
early and late passage WI-38 ¢broblasts. The protein is distributed in the cytoplasm, while the signal is signi¢cantly increased (arrow) in the
senescent cells. The nucleus (n) in both cellular states appears devoid of any immuno£uorescence. ApoJs: secreted Apo J form (V80 kDa);
ApoJc: cytoplasmic Apo J form (V68 kDa); ApoJsK,L : K- and L-chains of the secreted Apo J form following reduction of the protein (V40
kDa); bars in D: 10 Wm. Molecular weight markers (in kDa) are indicated on the left of each blot.
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weakly associate with di¡erent proteins in proliferating or
senescent ¢broblasts under conditions other than those used
here, on the basis of the demonstrated recognition pattern of
the antibodies used, we suggest that Apo J overexpression in
senescent HDFs is not coupled with a di¡erentiated pattern in
terms of protein^protein interactions.
3.3. Stable overexpression of the Apo J gene does not a¡ect the
proliferative capacity of WI-38 or WI-38/SV40 T Ag
¢broblasts
The appearance of the replicative senescence phenotype in
primary cells is accompanied by the di¡erential expression
(negative or positive growth e¡ectors) of a signi¢cant number
of genes (see Section 1). However, despite the high number of
senescence-related cloned genes only a limited number of them
was shown to a¡ect normal life-span when overexpressed in
either immortal or primary mammalian cells (see Section 4). A
major question, therefore, when analyzing the function of a
senescence biomarker (such as Apo J), is whether the observed
di¡erentiated gene expression is directly related to the induc-
tion of the senescence phenotype or represents a secondary
event of replicative senescence. Thus we have overexpressed
the human Apo J gene in both primary and SV40 T Ag-im-
mortalized WI-38 ¢broblasts and determined the gene’s ability
to alter the proliferative capacity of the transduced cells.
The full-length human Apo J cDNA was cloned into the
expression vector pcDNA3.1 and introduced by electropora-
tion into the WI-38/SV40 T Ag ¢broblasts, and after appro-
priate antibiotic selection several colonies were isolated and
expanded into cell lines. Selected clones were then tested for
Apo J protein expression levels by immunoblotting analysis.
As demonstrated in Fig. 3A,B for two representative clones
(WI-38/SV40 T AgApoJ2:1 and WI-38/SV40 T AgApoJ2:5) the
introduced construct results in signi¢cant overexpression of
both the 68 kDa and 80 kDa Apo J forms (Fig. 3A, lanes
7^10). Moreover, the engineered Apo J protein is processed
along the secretory pathway and secreted in the cell culture
supernatants (Fig. 3B, lanes 7^10) exactly as their endogenous
counterparts in the parental WI-38/SV40 T Ag (Fig. 3A,B,
lanes 3, 4) and the WI-38 (Fig. 3A,B, lanes 1, 2) cells. No
Apo J overexpression was seen when cells were transfected
with the empty pcDNA3.1 vector (WI-38/SV40 T
AgpcDNA3:1 ; Fig. 3A,B, lanes 5, 6). It is worth mentioning
that the di¡erence noticed in the Apo J expression levels be-
tween the WI-38/SV40 T Ag and the WI-38 primary ¢bro-
blasts is consistent with previous data showing that senes-
cence-induced genes are suppressed in immortalized and/or
transformed cells [8,33]. All the obtained Apo J-overexpress-
ing WI-38/SV40 T AgApoJ cell lines did not show any di¡er-
ence in cell morphology when compared with the non-trans-
fected WI-38/SV40 T Ag or with the WI-38/SV40 T
AgpcDNA3:1 cells. Moreover, growth rates between the parental
cell line and the WI-38/SV40 T AgApoJ clones were similar
even after several months of subcultivation (data not shown).
It is therefore apparent that Apo J overexpression in the WI-
38/SV40 T Ag immortal cell line does not induce any of the
replicative senescence-related morphological alterations and
does not a¡ect the cellular growth rate.
Since SV40 T Ag binds several proteins involved in the
regulation of irreversible growth arrest and senescence (for
example p53) we pursued our studies by examining whether
Apo J overexpression in primary WI-38 cells can a¡ect the
growth rate and the proliferative life-span of these cells. The
full-length human Apo J cDNA was cloned into the pBabe-
puro vector and introduced by retrovirus-mediated gene
transfer in early passage proliferating WI-38 ¢broblasts. Fol-
lowing initial antibiotic selection, cells infected with the Apo
J-encoded retrovirus (WI-38ApoJ ; we have avoided the clonal
selection step that could exhaust the limited proliferative ca-
pacity of primary cells) were examined by immunoblotting for
Apo J expression levels (Fig. 3C, upper panel, lane 3), in
parallel with cells infected with the empty retroviral vector
(WI-38pBabeÿpuro) and parental cells (WI-38; Fig. 3C, upper
panel, lanes 2 and 1 respectively). Apo J-infected cells were
found to express almost 10 times higher Apo J levels as com-
pared to control vector-infected or uninfected human ¢bro-
blasts. All cell types (WI-38, WI-38pBabeÿpuro and WI-38ApoJ)
were propagated until they reached replicative senescence as
concluded by the development of several markers related to
the senescence phenotype (i.e. senescence-associated L-galac-
tosidase activity, morphological features and DNA synthesis
levels). WI-38 cells reached senescence at mean CPD 45, WI-
38pBabeÿpuro cells at CPD 44 and WI-38ApoJ cells at CPD 47
(average values of two independent experiments; Fig. 1D).
Furthermore, the cells were kept for over 3 months in culture
and no clones with extended life-span or with immortal phe-
notype emerged. In addition no di¡erences were observed in
cell morphology, growth rates or expression level of the cy-
clin-dependent kinase inhibitor p21Waf1=Cip1=Sdi1 (an estab-
lished biomarker of senescence; Fig. 3C, middle panel) among
the Apo J-infected and control cells during the selection pro-
cess and subsequent subcultivation. Therefore these data sug-
gest that, as was found in WI-38/SV40 T Ag Apo J trans-
Fig. 2. Representative Apo J immunoprecipitation from whole cell
extracts of early (E) and late passage (L) WI-38 ¢broblasts. Equal
numbers of early and late passage cells were lysed with 1% NP-40
lysis bu¡er and Apo J was immunoprecipitated using a goat anti-
human Apo J polyclonal antibody as described in Section 2. The se-
creted (ApoJs) and cytoplasmic (ApoJc) Apo J forms are indicated.
Stars indicate enriched polypeptides which we are currently identify-
ing by mass spectrometry. Molecular weight markers (in kDa) are
shown on the left of the autoradiographs.
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Fig. 3. Apo J protein levels following stable transfection of pcDNA3.1ApoJ and retroviral infection of pBabe-puroApoJ constructs into the WI-
38/SV40 T Ag (A,B) and WI-38 ¢broblasts (C) respectively. A,B: Immunoblotting analysis of the Apo J protein levels, under reducing (R) and
non-reducing (NR) conditions, in whole cell lysates (A) and cell culture supernatants (B). Lanes 1, 2: WI-38 cells; lanes 3, 4: WI-38/SV40 T
Ag cells; lanes 5, 6: WI-38/SV40 T AgpcDNA3:1 cells ; lanes 7, 8 and 9, 10: WI-38/SV40 T AgApoJ2:1 and WI-38/SV40 T AgApoJ2:5 selected clones
respectively. C: Apo J expression levels in whole cell lysates of WI-38 (lane 1), WI-38pBabeÿpuro (lane 2) and WI-38ApoJ ¢broblasts (lane 3;
upper panel); p21Waf1=Cip1=Sdi1 (middle panel) and actin (lower panel) levels in the same cells at CPD 28. D: Maximum CPDs reached in WI-
38, WI-38pBabeÿpuro and WI-38ApoJ cells. Values represent the mean of two independent experiments. ApoJs: secreted Apo J form (V80 kDa);
ApoJc: cytoplasmic Apo J form (V68 kDa); ApoJsL, ApoJsK : L- (V40 kDa) and K-chain (V35 kDa) respectively, of the secreted Apo J
form following reduction of the protein. Molecular weight markers (in kDa) are indicated on the left of each blot.
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fectants, Apo J overexpression does not a¡ect normal life-
span in WI-38 ¢broblasts. Similar results were also obtained
following overexpression of human Apo J cDNA in REFs
isolated from 12-day-old rat embryos. As in HDFs, Apo J
stable overexpression did not a¡ect the replicative life-span
of transfected cells as compared with their control counter-
parts (data not shown). In agreement with these data, retro-
viral infection of a canine Apo J construct in WI-38 ¢bro-
blasts also did not a¡ect normal life-span (Dumont et al.,
submitted). In conclusion, these data demonstrate that stable
Apo J overexpression does not a¡ect the proliferative capacity
of human ¢broblasts.
3.4. WI-38 and WI-38/SV40 T Ag ¢broblasts overexpressing
Apo J exhibit survival and growth ability to H2O2-induced
cytotoxicity similar to their parental cell lines
Recent studies focused on the Apo J function have revealed
that it may act as a survival gene against cytotoxic stresses
induced by di¡erent kinds of agents (see Section 1). These
studies, however, are related exclusively to tumor-derived
cell lines. Exposure of proliferating mammalian ¢broblasts
to various H2O2 concentrations can induce temporary growth
arrest (100^120 WM), irreversible growth arrest (150^450 WM),
or apoptosis (500^1000 WM) (reviewed in [34]). We [12] and
others [35] have shown that treatment of young WI-38 ¢bro-
blasts with H2O2 concentrations ranging from 150 to 450 WM
(single treatments) results in the eventual induction of a sen-
escence-like phenotype, which is accompanied by a signi¢cant
overexpression of Apo J mRNA levels. Moreover, initial anal-
ysis has shown that WI-38 and WI-38/S40 T Ag ¢broblasts
treated with various H2O2 concentrations exhibit an approx-
imate two-fold increase in Apo J protein synthesis 24 h after
treatment (data not shown), which is in agreement with pre-
vious reports in tumor-derived cell lines [19]. Therefore we
have addressed two complementary and interrelated ques-
tions: (a) whether Apo J acts as a survival factor in primary
or immortalized cells as is the case in tumor-derived cell lines
and (b) whether WI-38 and WI-38/SV40 T Ag Apo J-over-
expressing cells exhibit di¡erent growth rates after H2O2 treat-
ment, as compared to parental cell lines.
We have established ¢rst the H2O2 concentrations at which
there is induction of apoptosis in WI-38/SV40 T Ag ¢bro-
blasts. Cells were treated with a range of H2O2 concentrations
for 2 h and assayed for initiation of apoptosis by TUNEL. As
shown in Fig. 4A and in accordance with previous reported
data [34], only V10% of cells treated with 400 WM H2O2 were
found to undergo apoptosis (the remaining cells eventually
entered a state of irreversible growth arrest). However and
as expected, apoptosis was massive at much higher H2O2 con-
centrations (800 or 1000 WM) as V75% and V90% of treated
cells respectively were found to be apoptosis-positive (Fig.
4A). Treatment of WI-38/SV40 T Ag, WI-38/SV40 T
AgpcDNA3:1 and WI-38/SV40 T AgApoJ2:1 and 2:5 cell lines with
800 WM H2O2 for 2 h did not result in any signi¢cant di¡er-
ence in their survival rates, as indicated by the trypan blue
method (Fig. 4B). Similar results were also obtained at 400
WM H2O2, where apoptosis is only present at basal levels (Fig.
4C); these results, regarding the ability of the various clones
to survive H2O2 treatment, were also veri¢ed by comparative
TUNEL analysis (data not shown). We then examined
whether stable Apo J overexpression in immortalized ¢bro-
blasts could inhibit or retard the growth arrest induction ob-
served after treatment of cells with moderate H2O2 concen-
trations. Cells were seeded in clonal density, exposed to 100
WM H2O2 for 2 h, allowed to recover from the shock, prolif-
erated for 7 days and the formed colonies were recorded as
described in Section 2. As demonstrated in Fig. 4D, no sig-
ni¢cant di¡erence was seen among the Apo J-overexpressing
clones and the control cells. Similar results were also obtained
when cells were treated with 400 WM H2O2, which induces a
permanent growth arrest (data not shown). Finally we also
treated WI-38, WI-38pBabeÿpuro and WI-38ApoJ cells at CPD 28
with 400 WM H2O2 for 2 h. All cells exhibited similar survival
rates and they reached a state of irreversible growth arrest
after 5^7 CPD. It is thus evident that Apo J overexpression
in either primary or SV40 T Ag-immortalized WI-38 ¢bro-
blasts does not confer increased resistance to oxidative stress
induced by H2O2. In support of the reported data, in an
independent study by the Toussaint laboratory, it was also
found that overexpression of the canine homologue of human
Apo J, the gp80 gene, in WI-38 or WI-38/SV40 T Ag cells did
not confer increased resistance to H2O2 (Dumont et al., sub-
mitted). Interestingly, in a tumor-derived cell line (LLC-PK1
cells), Apo J does protect against H2O2 [28]. This discrepancy
regarding the cytoprotective function of Apo J reported in
tumor-derived cell lines as opposed to Apo J cytoprotective
inability found in primary or SV40 T Ag-immortalized WI-38
¢broblasts is further documented by additional data from
our laboratory. Treatment of two clones (WI-38/SV40 T
AgApoJ2:1 and 2:5) with the chemotherapeutic drug doxorubicin
does not result in higher survival rates as compared with the
parental cell lines (data not shown). However, U2-OS and
KHOS osteosarcoma cell lines stably transfected with the
Apo J construct used in this study (pcDNA3.1ApoJ) have a
signi¢cantly increased resistance against the same drug (Trou-
gakos et al., submitted).
4. Discussion
In this article we have shown the senescence-related induc-
tion of Apo J RNA levels and two protein forms and we
provided evidence for no Apo J-altered biogenesis, partner
binding, or intracellular distribution between cellular prolifer-
ation and senescence. Furthermore, we demonstrated that sta-
ble human Apo J overexpression in primary or SV40 T Ag-
immortalized human ¢broblasts did not a¡ect their prolifer-
ative capacity and did not protect them from H2O2-mediated
cytotoxicity.
Two Apo J forms with apparent molecular weights of 80
and 68 kDa were detected, both found up-regulated during
senescence. Of these forms, the 80 kDa is constitutively se-
creted and can be dissociated into two subunits under reduc-
ing conditions indicating that it has been appropriately
cleaved at the Asp227-Ser228 residues [14]. The 68 kDa Apo
J form is not reduced and is retained intracellularly, with no
altered binding partner pro¢le or intracellular distribution
during senescence. Our observations are in agreement with
those of Humphreys et al. [17] who showed the existence of
a 80 kDa and an uncleaved 68 kDa Apo J form in L929 cells.
Similar forms have been found in HepG2 [36] and MDCK
cells [37] as well as in normal and regressing rat prostate cells
[25]. In these studies it has been suggested that the high mo-
lecular weight Apo J form represents the mature glycosylated
protein, while the low molecular weight form is a partially
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glycosylated uncleaved precursor that is retained intracellu-
larly [25]. Therefore the two forms we found in HDFs should
correspond to the Apo J polypeptides previously described
suggesting that the Apo J post-translational processing is nei-
ther cell type-dependent nor di¡erentiated among normal and
cancer cells. In addition, the absence of an altered binding
pro¢le and protein^protein interaction of Apo J during sen-
escence is in accordance with previous reports (no protein co-
immunoprecipitates speci¢cally with Apo J in heat-shocked
A4321 cells) [19] and indicates a rather conserved panel of
proteins that can interact (at least intracellularly) with Apo
J. Although apoptosis-related truncated Apo J forms that
either remain in the cytoplasm or accumulate in the nucleus
have also been reported [17,24,25,27], we did not detect any
senescence-speci¢c Apo J form or translocation of Apo J to
the nucleus. Thus, we propose that Apo J biogenesis is not
altered following the induction of HDF senescence. Overall, it
is obvious that these two distinct Apo J processing pathways
related to post-translational protein maturation and to Apo J
constitutive secretion do not depend on whether cells are ac-
tively proliferating or whether they enter a state of irreversible
growth arrest.
Numerous genes have been cloned up to now on the basis
of their di¡erential expression during cellular senescence in
various mammalian models [5^8]. In fact, using oligonucleo-
tide-based arrays, it was found that about 1% of the examined
genes are di¡erentially regulated upon aging in vitro or in vivo
[9,10]. The identi¢ed senescence-related genes are involved in
a variety of di¡erent cellular functions; they encode extracel-
lular matrix (ECM) proteins, cell cycle control proteins, chap-
erones, proteins involved in DNA synthesis and repair, in
chromosomal processing and assembly, in protein processing,
etc. [9,10,38]. These data demonstrate the functional hetero-
geneity of senescence-related genes and they strongly suggest
that senescence (and most likely mammalian aging) is unlikely
to be controlled by a single gene family (reviewed in [39]). An
important issue that we need to address in full is whether the
di¡erential expression of the veri¢ed genes is directly related
to the appearance of the senescent phenotype or not. How-
ever, for only a few of the isolated genes there is, so far,
evidence supporting their direct implication in the induction
or inhibition of senescence. These genes can be classi¢ed in
two main categories. First, those that when overexpressed
promote growth arrest, such as the cyclin-dependent kinase
inhibitors, p21Waf1=Cip1=Sdi1, p16INK4A and p15INK4B [40,41],
the promyelocytic leukemia protein, PML [42], the HSP70
family member, mortalin-1 [43], the nuclear localized protein,
Hic-5 [44], the ras oncogene [45] and the transcription factor,
MORF4 [46]. Second, those that extend the proliferative life-
span; the only known examples are the human telomerase
gene, hTERT [47] and the helix-loop-helix protein, Id-1 [48].
For all the remaining genes either there is no experimental
evidence up to now or they cannot exclusively account for
the phenotypic changes that occur during senescence (for ex-
ample, the ECM genes). Since Apo J overexpression does not
appear to induce any of these cellular responses we suggest
that Apo J falls in the category of the numerous genes that are
not a prerequisite for the appearance of the senescence phe-
notype but are induced due to a secondary response and as a
result of cell adaptation to a new ‘situation’.
There is an association between Apo J increased expression
and a wide variety of physiological disturbances, diseases as
well as ‘stress’ conditions (see Section 1). It is clear that Apo J
is an oxidative stress-responsive gene and is up-regulated fol-
lowing cell exposure to H2O2 [12,35]. Moreover, exogenously
added puri¢ed Apo J can protect kidney LLC-PK1 cells from
cell death mediated by H2O2 or aminotriazole and 1-chloro-
2,4-dinitrobenzene exposure [28] suggesting that in these cells
Apo J acts as an anti-oxidant. It has thus been proposed that
the main site of Apo J action is extracellular [14,15] and that
Apo J represents a new class of very e⁄cient chaperones sim-
ilar to the small heat shock proteins (HSP) [49] ; the enhanced
secretion rate of Apo J in senescent cells favors this hypoth-
esis. Interestingly, microarray analysis showed that the HSP27
gene is up-regulated about 3^4-fold during aging [9], while
HSP27 can also prevent apoptotic cell death [50]. In addition,
it has been proposed that Apo J might act as a molecular
adapter that targets the cellular debris of dead cells to speci¢c
cell surface receptors for internalization [23] thus participating
in a cellular ‘clearance’ system. On the basis of these obser-
vations, the inability of Apo J to confer protection against
H2O2-mediated oxidative stress in normal or immortalized
human ¢broblasts seems puzzling. A possible explanation
could be that as might be expected the e¡ects of many stimuli,
whether redox-active or not, depend on the cellular machinery
that translates the signal into a biological response. Because of
di¡erences in cellular composition, a single stimulus can exert
profoundly di¡erent e¡ects in di¡erent cell types on a dose-
dependent basis. This assumption is apparently enhanced
when cancer and normal cells are compared and is evident
in the elegant studies of Collart et al. [51] who showed that
the e¡ects of H2O2 and IR on c-jun induction in various cell
types ranged from dramatic increases to no e¡ect at all. Thus,
in the case of human ¢broblasts the endogenous Apo J up-
regulation achieved following exposure to a certain H2O2
amount might be enough to saturate the cell and confer the
necessary protection, since cells normally will not experience a
concentration of 100 WM of H2O2 or higher. Alternatively in
tumor-derived cell lines a speci¢c signaling pathway that reg-
ulates Apo J function may be altered thereby resulting in the
enhanced cytoprotective action of the molecule in these cells.
Current work in the laboratory is focusing to unravel this very
intriguing issue.
Senescent cells are relatively oxidized as compared to early
passage proliferating cells [52]. In addition, stress-induced pre-
mature senescence of HDFs that can be induced by H2O2
6
Fig. 4. E¡ect of H2O2 treatment in WI-38/SV40 T Ag and WI-38/SV40 T Ag clones overexpressing Apo J. A: Determination of H2O2 (400,
600, 800 and 1000 WM)-induced cellular apoptosis using TUNEL assay in WI-38/SV40 T Ag cells. In each optical ¢eld presented about 28^32
cells occur; however, only the £uorescent-positive apoptotic nuclei can be seen. The percentage of apoptotic nuclei to the cells seeded was
found to be V10% at 400 WM, V17% at 600 WM, V75% at 800 WM, and almost 90% at 1000 WM of H2O2. B,C: Cell viability assessment ac-
cording to the trypan blue exclusion method, following treatment of WI-38/SV40 T Ag (1), WI-38/SV40 T AgpcDNA3:1 (2), WI-38/SV40 T
AgApoJ2:1 (3), and WI-38/SV40 T AgApoJ2:5 cells (4) with 800 (B) or 400 WM (C) H2O2 for 2 h and cell recovery for 24 h in complete medium.
No signi¢cant di¡erence in viability is seen between the di¡erent cell types. D: Colony formation ability after cell treatment with 100 WM
H2O2 for 2 h and cell proliferation in complete medium for 7 days. Bars (see Section 2) correspondence is as in B and C.
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treatment [53] is a state reminiscent of replicative senescence
that among other changes also induces Apo J accumulation
[35]. Thus it is plausible that during senescence Apo J accu-
mulation and oversecretion might correlate with either a re-
sponse to a higher cellular oxidation state and an increased
necessity to control and refold partially unfolded molecules
[54] or to the cells’ attempt to establish a ‘surveillance’ and/
or a ‘clearance’ system. Even if this hypothesis regarding Apo
J function during senescence is correct, a more fundamental
issue remains partially addressed: what exactly replicative sen-
escence assays for? Despite the important data from the elab-
orate work by the Cristofalo group, regarding the lack of
correlation between donor age and maximum life-span of
the derived skin ¢broblast cultures [55], the ‘Hay£ick replica-
tive senescence model’ remains a very valuable system for
studying mammalian aging in vitro. Among the various
achievements, after using such in vitro systems during the
last four decades, several aging biomarkers have been identi-
¢ed (reviewed in [3]). However, we should also bear in mind
that culturing cells in vitro, under routinely applied condi-
tions, is per se a stress-inducing phenomenon as cells are
experiencing high oxygen, etc. It is, therefore, not surprising
that: (a) senescence-associated genes are also up-regulated in
stress conditions (for example culturing established cell lines
at high temperatures [12]) and (b) several stress-induced genes,
such as the HSPs, have also been identi¢ed in aging models
[9]. Further studies are needed to unravel fully the exact link
between these biological processes.
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